Probability of developing proximal deep-vein thrombosis and/or pulmonary embolism after distal deep-vein thrombosis

Thrombosis and Haemostasis

Volumn 115, Issue 3, 2016, Pages 608-614

  Brateanu, Andrei ^a   Patel, Krishna ^a   Chagin, Kevin ^a   Tunsupon, Pichapong ^a   Yampikulsakul, Pojchawan ^a   Shah, Gautam V ^a   Wangsiricharoen, Sintawat ^a   Amah, Linda ^a   Allen, Joshua ^a   Shapiro, Aryeh ^a   Gupta, Neha ^a   Morgan, Lillie ^a   Kumar, Rahul ^a   Nielsen, Craig ^a   Rothberg, Michael B ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Deep vein thrombosis; Distal deep vein thrombosis; Proximal deepvein thrombosis; Pulmonary embolism

Indexed keywords

ANTICOAGULANT AGENT;

AGED; COMPLICATION; FEMALE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROBABILITY; PULMONARY EMBOLISM; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOEMBOLISM; VENOUS THROMBOSIS; X-RAY COMPUTED TOMOGRAPHY;

AGED; ANTICOAGULANTS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROBABILITY; PULMONARY EMBOLISM; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM; TOMOGRAPHY, X-RAY COMPUTED; VENOUS THROMBOSIS;

EID: 84964742431     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH15-06-0503     Document Type: Article

References (13)

1. De Martino RR, Wallaert JB, Rossi AP, et al. A meta-analysis of anticoagulation for calf deep venous thrombosis. J Vasc Surg 2012; 56: 228–237 e1.
2. Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl): e419S-94S.
3. Ciuti G, Grifoni E, Pavellini A, et al. Incidence and characteristics of asymptomatic distal deep vein thrombosis unexpectedly found at admission in an Internal Medicine setting. Thromb Res 2012; 130: 591–595.
4. Anderson FA, Jr., Spencer FA. Risk factors for venous thromboembolism. Circulation 2003; 107 (23 Suppl 1): I9–16.
5. Harrell FE. Regression modeling strategies: With applications to linear models, logistic regression, and survival analysis. 45. New York: Springer; 2001. pp. 1–67.
6. Palareti G, Schellong S. Isolated distal deep vein thrombosis: what we know and what we are doing. J Thromb Haemost 2012; 10: 11–19.
7. Galanaud JP, Quenet S, Rivron-Guillot K, et al. Comparison of the clinical history of symptomatic isolated distal deep-vein thrombosis vs. proximal deep vein thrombosis in 11 086 patients. J Thromb Haemost 2009; 7: 2028–2034.
8. Baglin T, Douketis J, Tosetto A, et al. Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis. J Thromb Haemost 2010; 8: 2436–2442.
9. Galanaud JP, Sevestre-Pietri MA, Bosson JL, et al. Comparative study on risk factors and early outcome of symptomatic distal versus proximal deep vein thrombosis: results from the OPTIMEV study. Thromb Haemost 2009; 102: 493–500.
10. Galanaud JP, Sevestre MA, Genty C, et al. Incidence and predictors of venous thromboembolism recurrence after a first isolated distal deep vein thrombosis. J Thromb Haemost 2014; 12: 436–443.
11. Fahrni J, Husmann M, Gretener SB, et al. Assessing the risk of recurrent venous thromboembolism – a practical approach. Vasc Health Risk Manag 2015; 11: 451–459.
12. Sales CM, Haq F, Bustami R, et al. Management of isolated soleal and gastrocnemius vein thrombosis. J Vasc Surg 2010; 52: 1251–1254.
13. Schwarz T, Buschmann L, Beyer J, et al. Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study. J Vasc Surg 2010; 52: 1246–1250.